194 related articles for article (PubMed ID: 17563341)
1. Contribution of metabolic syndrome components to cognition in older individuals.
Dik MG; Jonker C; Comijs HC; Deeg DJ; Kok A; Yaffe K; Penninx BW
Diabetes Care; 2007 Oct; 30(10):2655-60. PubMed ID: 17563341
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine and inflammation: predictors of cognitive decline in older persons?
van den Kommer TN; Dik MG; Comijs HC; Jonker C; Deeg DJ
Neurobiol Aging; 2010 Oct; 31(10):1700-9. PubMed ID: 19004529
[TBL] [Abstract][Full Text] [Related]
3. Systemic markers of inflammation and cognitive decline in old age.
Schram MT; Euser SM; de Craen AJ; Witteman JC; Frölich M; Hofman A; Jolles J; Breteler MM; Westendorp RG
J Am Geriatr Soc; 2007 May; 55(5):708-16. PubMed ID: 17493190
[TBL] [Abstract][Full Text] [Related]
4. Serum high sensitivity C-reactive protein and cognitive function in elderly women.
Komulainen P; Lakka TA; Kivipelto M; Hassinen M; Penttilä IM; Helkala EL; Gylling H; Nissinen A; Rauramaa R
Age Ageing; 2007 Jul; 36(4):443-8. PubMed ID: 17537742
[TBL] [Abstract][Full Text] [Related]
5. Cognitive decline and markers of inflammation and hemostasis: the Edinburgh Artery Study.
Rafnsson SB; Deary IJ; Smith FB; Whiteman MC; Rumley A; Lowe GD; Fowkes FG
J Am Geriatr Soc; 2007 May; 55(5):700-7. PubMed ID: 17493189
[TBL] [Abstract][Full Text] [Related]
6. The metabolic syndrome is associated with decelerated cognitive decline in the oldest old.
van den Berg E; Biessels GJ; de Craen AJ; Gussekloo J; Westendorp RG
Neurology; 2007 Sep; 69(10):979-85. PubMed ID: 17785666
[TBL] [Abstract][Full Text] [Related]
7. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
8. Role of lipoproteins and inflammation in cognitive decline: do they interact?
van den Kommer TN; Dik MG; Comijs HC; Jonker C; Deeg DJ
Neurobiol Aging; 2012 Jan; 33(1):196.e1-12. PubMed ID: 20594617
[TBL] [Abstract][Full Text] [Related]
9. Serum C3 is a stronger inflammatory marker of insulin resistance than C-reactive protein, leukocyte count, and erythrocyte sedimentation rate: comparison study in an elderly population.
Muscari A; Antonelli S; Bianchi G; Cavrini G; Dapporto S; Ligabue A; Ludovico C; Magalotti D; Poggiopollini G; Zoli M;
Diabetes Care; 2007 Sep; 30(9):2362-8. PubMed ID: 17595349
[TBL] [Abstract][Full Text] [Related]
10. The association between circulating inflammatory markers and metabolic syndrome in Korean rural adults.
Ryu SY; Kim KS; Park J; Kang MG; Han MA
J Prev Med Public Health; 2008 Nov; 41(6):413-8. PubMed ID: 19037171
[TBL] [Abstract][Full Text] [Related]
11. The effect of chronic benzodiazepine use on cognitive functioning in older persons: good, bad or indifferent?
Bierman EJ; Comijs HC; Gundy CM; Sonnenberg C; Jonker C; Beekman AT
Int J Geriatr Psychiatry; 2007 Dec; 22(12):1194-200. PubMed ID: 17407168
[TBL] [Abstract][Full Text] [Related]
12. [Serum markers in relation to cognitive functioning in an aging population: results of the Maastricht Aging Study (MAAS)].
Teunissen CE; van Boxtel MP; Bosma H; Jolles J; Lütjohann D; von Bergmann K; Wauters A; Bosmans E; Maes M; Delanghe J; De Bruijn C; Steinbusch HW; Blom HJ; de Vente J
Tijdschr Gerontol Geriatr; 2003 Feb; 34(1):6-12. PubMed ID: 12629905
[TBL] [Abstract][Full Text] [Related]
13. Impaired cognitive performance in asymptomatic peripheral arterial disease: relation to C-reactive protein and D-dimer levels.
Mangiafico RA; Sarnataro F; Mangiafico M; Fiore CE
Age Ageing; 2006 Jan; 35(1):60-5. PubMed ID: 16364935
[TBL] [Abstract][Full Text] [Related]
14. High-sensitivity C-reactive protein and cognitive function in older women.
Weuve J; Ridker PM; Cook NR; Buring JE; Grodstein F
Epidemiology; 2006 Mar; 17(2):183-9. PubMed ID: 16477259
[TBL] [Abstract][Full Text] [Related]
15. Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population.
Sung SH; Chuang SY; Sheu WH; Lee WJ; Chou P; Chen CH
Am J Cardiol; 2009 May; 103(10):1411-6. PubMed ID: 19427438
[TBL] [Abstract][Full Text] [Related]
16. Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study.
Jacobs M; van Greevenbroek MM; van der Kallen CJ; Ferreira I; Blaak EE; Feskens EJ; Jansen EH; Schalkwijk CG; Stehouwer CD
Eur J Clin Invest; 2009 Jun; 39(6):437-44. PubMed ID: 19397692
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome and cognitive disorders: is the sum greater than its parts?
Yaffe K
Alzheimer Dis Assoc Disord; 2007; 21(2):167-71. PubMed ID: 17545744
[TBL] [Abstract][Full Text] [Related]
18. Association between apolipoprotein E4 and cognitive decline in elderly adults.
Packard CJ; Westendorp RG; Stott DJ; Caslake MJ; Murray HM; Shepherd J; Blauw GJ; Murphy MB; Bollen EL; Buckley BM; Cobbe SM; Ford I; Gaw A; Hyland M; Jukema JW; Kamper AM; Macfarlane PW; Jolles J; Perry IJ; Sweeney BJ; Twomey C;
J Am Geriatr Soc; 2007 Nov; 55(11):1777-85. PubMed ID: 17979899
[TBL] [Abstract][Full Text] [Related]
19. Mental slowness and executive dysfunctions in patients with metabolic syndrome.
Segura B; Jurado MA; Freixenet N; Albuin C; Muniesa J; Junqué C
Neurosci Lett; 2009 Oct; 462(1):49-53. PubMed ID: 19560512
[TBL] [Abstract][Full Text] [Related]
20. Association of metabolic syndrome with cognitive function: the role of sex and age.
Laudisio A; Marzetti E; Pagano F; Cocchi A; Franceschi C; Bernabei R; Zuccalà G
Clin Nutr; 2008 Oct; 27(5):747-54. PubMed ID: 18715681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
